Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Total Liabilities (2016 - 2025)

Innospec (IOSP) has disclosed Total Liabilities for 16 consecutive years, with $499.5 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities fell 3.68% to $499.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $499.5 million through Dec 2025, down 3.68% year-over-year, with the annual reading at $499.5 million for FY2025, 3.68% down from the prior year.
  • Total Liabilities hit $499.5 million in Q4 2025 for Innospec, up from $496.5 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $577.3 million in Q3 2022 to a low of $467.0 million in Q1 2021.
  • Historically, Total Liabilities has averaged $524.7 million across 5 years, with a median of $517.3 million in 2023.
  • Biggest five-year swings in Total Liabilities: rose 19.54% in 2021 and later fell 15.04% in 2023.
  • Year by year, Total Liabilities stood at $537.9 million in 2021, then rose by 4.72% to $563.3 million in 2022, then dropped by 0.98% to $557.8 million in 2023, then decreased by 7.03% to $518.6 million in 2024, then decreased by 3.68% to $499.5 million in 2025.
  • Business Quant data shows Total Liabilities for IOSP at $499.5 million in Q4 2025, $496.5 million in Q3 2025, and $504.6 million in Q2 2025.